Why patient centricity is the answer to the clinical trial enrolment gap
Pharmaceutical Technology
FEBRUARY 13, 2024
Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance.
Sat.Feb 10, 2024 - Fri.Feb 16, 2024
147 
What We Can Learn from Minority Experiences in Clinical Trials
ACRP blog
FEBRUARY 13, 2024
“If we are to improve diversity in clinical trials, we need to understand minority experiences, and how these can be improved to support recruitment and retention,” says Heidi Green, PhD, Director of Health Research Equity, COUCH Health. “The Minority Experiences in Clinical Trials (MERIT) project set out to understanding why ethnic minorities are underrepresented, using a qualitative evidence synthesis to identify factors that influence recruitment.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
What I love About Being a CRA (Clinical Research Associate)
ECRG Media's Clinical Research Podcast
FEBRUARY 14, 2024
What I love About Being a CRA Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group o
ICMR issues comprehensive guidance on ethical requirements for laboratory validation testing
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 12, 2024
In a significant move aimed at upholding ethical standards in the realm of medical research, the Indian Council of Medical Research (ICMR) has recently released detailed guidelines on the ethical requirements for laboratory validation testing.
February 14, 2024: In This Friday’s PCT Grand Rounds, Clinical Implications of the MINT Trial
Rethinking Clinical Trials
FEBRUARY 14, 2024
Dr. Jeffrey Carson In this Friday’s PCT Grand Rounds, Jeffrey Carson of Rutgers Biomedical and Health Sciences will present “Clinical Implications of the MINT Trial: p=0.07.” The Grand Rounds session will be held on Friday, February 16, 2024, at 1:00 pm eastern. Carson is provost-New Brunswick for Rutgers Biomedical and Health Sciences and the Distinguished Professor of Medicine and Richard C.
Alnylam change to heart drug trial sparks doubts, sinking shares
Bio Pharma Dive
FEBRUARY 15, 2024
Analysts pressed Alnylam executives on the reasons for the changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Obesity Disrupts Mitochondria, And We May Have Figured Out How
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 15, 2024
Scientists have revealed in unprecedented detail how obesity affects mitochondria in mice, causing the cellular powerhouses to fragment into smaller pieces. Mitochondria are famous as “powerhouses of the cell,” given their crucial role in generating energy. Yet the vital work of these organelles is often impaired in people with obesity, for reasons that remain unclear.
Mastering Ultra-Low Freezer Repair: A Comprehensive Guide
Pharma Mirror
FEBRUARY 14, 2024
In the dynamic realm of laboratory instruments, ultra-low freezers play a pivotal role in preserving valuable samples and reagents. These sophisticated devices are crucial for various fields, ranging from medical research to pharmaceutical development. Today, we delve into the nuances of ultra-low (also called so low) freezer repair, exploring their main applications and common troubleshooting issues.
Hunting a non-opioid painkiller, a biotech startup reveals plans to chase Vertex
Bio Pharma Dive
FEBRUARY 14, 2024
Latigo Biotherapeutics has raised $135 million to develop drugs that block NaV1.8, a target shared by a Vertex therapy that just succeeded in Phase 3 testing.
Psychedelic treatments for mental health: Is there substance behind the hype?
Pharmaceutical Technology
FEBRUARY 15, 2024
The success of recent trials treating mental health problems with psychedelic therapies has driven a rapid rise in investment in the area.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Simulations Reveal What Happens When a Sperm Kisses an Egg
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 14, 2024
The moment when a slithering sperm propels itself head-first into a gelatinous egg is one of sudden change. Within seconds to minutes, chemical changes in the egg’s membrane and outer coat are enacted to block any more sperm from attaching to and entering the oocyte.
FDA approves Iovance’s Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
FEBRUARY 16, 2024
The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunothera | The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunotherapy developed by Iovance Biotherapeutics.
Sage offers details on launch of new postpartum depression pill
Bio Pharma Dive
FEBRUARY 14, 2024
The company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the first oral therapy for PPD, is off to a good start.
UK Agency targets blood thinners in personalised medicine pursuit
Pharmaceutical Technology
FEBRUARY 13, 2024
The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Blood of Exceptionally Long-Lived People Reveals Key Differences
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2024
Centenarians, once considered rare, have become commonplace. Indeed, they are the fastest-growing demographic group of the world’s population, with numbers roughly doubling every ten years since the 1970s. How long humans can live, and what determines a long and healthy life, have been of interest for as long as we know.
2024 predictions: Experts comment on AI, ML and automation
Drug Discovery World
FEBRUARY 12, 2024
DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in the sector. Updesh Dosanjh, Practice Leader for Pharmacovigilance Technology Solutions, IQVIA “In 2024, the traditional pain points of the pharmacovigilance (PV) space will not disappear.
ALS drug from Denali, Sanofi falls short in mid-stage study
Bio Pharma Dive
FEBRUARY 16, 2024
The disclosure the experimental therapy missed its trial goal comes after Sanofi had earmarked the drug for advancement into Phase 3.
Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs
Pharmaceutical Technology
FEBRUARY 15, 2024
As the market is progressively becoming saturated by GLP-1 receptor agonists, companies are investigating alternative mechanisms of action.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
When You Got Your Period May Impact Dementia Risk, Study Finds
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 13, 2024
The ages at which a person starts and stops menstruating could impact their risk of developing dementia later in life, according to the largest study of its kind.
PrecisionLife partners with Metrodora Institute to offer new hope for long COVID sufferers
BioPharma Reporter
FEBRUARY 15, 2024
PrecisionLife has partnered with healthcare center the Metrodora Institute to jumpstart the diagnosis and treatment options for a range of chronic diseases including long COVID, ME/CFS, ALS and SjÃgren's syndrome.
Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies
Bio Pharma Dive
FEBRUARY 16, 2024
Kelonia will receive $40 million upfront through a partnership to develop “off-the-shelf” cell therapies for cancer.
Otsuka wins FDA breakthrough therapy designation for IgAN drug
Pharmaceutical Technology
FEBRUARY 16, 2024
This positive news comes after Otsuka’s Phase III Alzheimer’s agitation trial failed to meet its primary endpoint, announced earlier this week.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expiry date for prescription necessary to prevent AMR: AICDF
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 14, 2024
The Kolkata headquartered All India Chemists and Distributors Federation (AICDF), a breakaway group of the AIOCD and a body of pharmaceutical distributors and retailers across the country, has informed the government of West Bengal that a period of use or an expiry date, on the lines of the use of therapeutics, is necessary for doctors’ […]
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Fierce Pharma
FEBRUARY 16, 2024
People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. | People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. The FDA has blessed Roche and Novartis’ Xolair as the first medicine to reduce allergic reactions that can occur with accidental exposure to certain foods.
Two GV partners on biotech’s reset and building their next drug startups
Bio Pharma Dive
FEBRUARY 13, 2024
Newly named partner Anthony Philippakis and managing partner Krishna Yeshwant spoke with BioPharma Dive about biotech’s newfound optimism and their investing “North Star.
FDA approves Eicos’s Aurlumyn for severe frostbite treatment
Pharmaceutical Technology
FEBRUARY 15, 2024
The US FDA has granted approval for Eicos Sciences' Aurlumyn for adults with severe frostbite to lower the risk of amputation.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Ayush Ministry to amend D&C Rules mandating cGMP for homoeopathic drug manufacturing license
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 13, 2024
The Union Ministry of Ayush will soon amend the Drugs and Cosmetic Rules, 1945 to mandate good manufacturing practices for Homoeopathy drug manufacturing, stipulating procedures for loan licensing in the system of Homoeopathy and specifying timelines for issuance of license, among others.
Positive results for MAIA’s SCLC treatment published in Nature Communications
Pharma Times
FEBRUARY 14, 2024
The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide
Gilead to buy CymaBay in $4.3B deal for liver disease drug
Bio Pharma Dive
FEBRUARY 12, 2024
The proposed acquisition is a bet on CymaBay’s drug seladelpar, which is now under FDA review in a chronic liver disease called primary biliary cholangitis.
GSK to license Elsie’s oligonucleotide discovery platform
Pharmaceutical Technology
FEBRUARY 15, 2024
GSK has exercised its option for a licence for Elsie Biotechnologies’ discovery platform to detect and develop new oligonucleotides.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Let's personalize your content